We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

116 hedge funds and large institutions have $226M invested in 2seventy bio in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 39 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $215M → $226M (+$11.7M)

18% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 39

20% less funds holding

Funds holding: 145116 (-29)

62% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 39

62% less call options, than puts

Call options by funds: $453K | Put options by funds: $1.19M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
116
Holders Change
-29
Holders Change %
-20%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
15
Increased
32
Reduced
39
Closed
39
Calls
$453K
Puts
$1.19M
Net Calls
-$734K
Net Calls Change
-$688K
Name Holding Trade Value Shares
Change
Change in
Stake
BC
101
Barrett & Company
Rhode Island
$282
Northwestern Mutual Wealth Management
102
Northwestern Mutual Wealth Management
Wisconsin
$248
FFA
103
Farther Finance Advisors
California
$248 +$178 +58 New
BWAM
104
Boyd Watterson Asset Management
Ohio
$175
TC
105
Truvestments Capital
Florida
$175
BCWM
106
Bartlett & Co Wealth Management
Ohio
$151
PFBT
107
Parkside Financial Bank & Trust
Missouri
$141
MSG
108
Main Street Group
Virginia
$140 +$101 +33 New
FFA
109
Fairfield Financial Advisors
Massachusetts
$85
DJSG
110
D.J. St. Germain
Massachusetts
$81
GRP
111
Global Retirement Partners
California
$53
SA
112
SRH Advisors
Kansas
$26
TFM
113
TFC Financial Management
Massachusetts
$18
LSA
114
Leonteq Securities AG
Switzerland
$4
NM
115
Newtyn Management
New York
-$12.1M -3,076,490 Closed
ECM
116
ExodusPoint Capital Management
New York
-$5.45M -1,389,953 Closed
CS
117
Credit Suisse
Switzerland
-$4.87M -1,243,449 Closed
Jacobs Levy Equity Management
118
Jacobs Levy Equity Management
New Jersey
-$3.06M -779,529 Closed
AA
119
AlphaCentric Advisors
Puerto Rico
-$2.58M -657,500 Closed
Balyasny Asset Management
120
Balyasny Asset Management
Illinois
-$2.5M -636,787 Closed
CCP
121
Clough Capital Partners
Massachusetts
-$2M -510,910 Closed
BC
122
Boxer Capital
California
-$1.8M -459,836 Closed
MCM
123
Moore Capital Management
New York
-$464K -118,313 Closed
Renaissance Technologies
124
Renaissance Technologies
New York
-$387K -98,839 Closed
Swiss National Bank
125
Swiss National Bank
Switzerland
-$385K -98,302 Closed

TSVT Hedge Fund Activity: Q4 2023 in Review

116 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2023, worth a combined $226M — up 5.4% from $215M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of TSVT and 15 opened new positions — a net loss of 24 holders — while 39 trimmed existing stakes and 32 added.

The largest buyer was Morgan Stanley, adding an estimated $25.6M. The largest seller was Newtyn Management, exiting entirely with an estimated $12.1M sold.

  • 116 institutional investors held 2seventy bio (TSVT) as of Q4 2023, down from 145 in Q3 2023.
  • Funds reported $226M of 2seventy bio stock for Q4 2023, up 5.4% quarter-over-quarter.
  • 15 funds opened new 2seventy bio positions in Q4 2023 and 39 closed out, a net change of -24 holders.
  • The largest 2seventy bio buyer in Q4 2023 was Morgan Stanley, an estimated $25.6M added.
  • The largest 2seventy bio seller in Q4 2023 was Newtyn Management, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2023.